FULC
Fulcrum Therapeutics, Inc. Common Stock
stockNASDAQ
what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.72 | 2026-09-28 | -0.89% | 0.530 |
| 1M | 3.85 | 2026-09-04 | -4.23% | 0.323 |
| 3M | 3.72 | 2026-07-06 | -0.89% | 0.344 |
| 6M | 7.83 | 2026-04-06 | -52.91% | 0.269 |
| 1Y | 9.50 | 2025-10-06 | -61.19% | 0.712 |
| 2Y | 3.82 | 2024-10-04 | -3.48% | — |
| 5Y | 24.96 | 2021-10-05 | -85.23% | 1.266 |
Fulcrum Therapeutics, Inc. Common Stock (NASDAQ:FULC) stock price today is $3.69, and today's volume is 1,540,441. FULC is up 0.190% today. The 30 day average volume is 1.40M. FULC market cap is $281.31M with 76.30M shares outstanding.